EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 -0.7164
March 31, 2026 -0.8262
December 31, 2025 -0.9599
September 30, 2025 -1.048
June 30, 2025 -1.135
March 31, 2025 -1.146
December 31, 2024 -1.136
September 30, 2024 -1.272
June 30, 2024 -1.344
March 31, 2024 -1.492
December 31, 2023 -1.545
September 30, 2023 -1.500
June 30, 2023 -1.505
March 31, 2023 -1.433
December 31, 2022 -1.462
September 30, 2022 -1.545
June 30, 2022 -1.624
March 31, 2022 -1.651
December 31, 2021 -1.487
September 30, 2021 -1.430
June 30, 2021 -1.240
March 31, 2021 -1.100
December 31, 2020 -1.169
September 30, 2020 -1.100
June 30, 2020 -1.119
Date Value
March 31, 2020 -1.136
December 31, 2019 -1.093
September 30, 2019 -1.061
June 30, 2019 -1.019
March 31, 2019 -0.962
December 31, 2018 -0.7643
September 30, 2018 0.0117
June 30, 2018 0.0018
March 31, 2018 -0.0303
December 31, 2017 -0.5524
September 30, 2017 -1.642
June 30, 2017 -3.012
March 31, 2017 -10.21
December 31, 2016 -18.96
September 30, 2016 -19.60
June 30, 2016 -37.32
March 31, 2016 -30.36
December 31, 2015 -21.60
September 30, 2015 -20.68
June 30, 2015 -1.802
March 31, 2015 -1.682
December 31, 2014 -1.922
September 30, 2014 -9.078
June 30, 2014 -10.44
March 31, 2014 -10.68

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Artivion, Inc. -0.0674
Glaukos Corp. -3.260
TransMedics Group, Inc. 3.844
Abbott Laboratories 3.094
AngioDynamics, Inc. -0.7897